Serum concentrations of resistin and adiponectin and their relationship to insulin resistance in subjects with impaired glucose tolerance

Journal of International Medical Research

Volumn 40, Issue 2, 2012, Pages 621-630

  Luo, R ^a   Li, X ^b,c,d   Jiang, R ^d   Gao, X ^c   Lu Z ^c   Hua, W ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b FUWAI HOSPITAL   (China)

^c AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

^d Provincial People's Hospital   (China)

Author keywords

Adiponectin; Impaired glucose tolerance; Insulin resistance; Interleukin 6; Leptin; Resistin; Tumour necrosis factor

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPONECTIN BLOOD LEVEL; ADULT; AGE; ARTICLE; BODY MASS; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MALE; OBESITY; PROTEIN BLOOD LEVEL; RESISTIN BLOOD LEVEL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

EID: 84860477422     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000224     Document Type: Article

References (43)

1. Galic S, Oakhill JS, Steinberg GR: Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010; 316: 129-139.
2. Harwood HJ Jr: The adipocyte as an endocrine organ in the regulation of metabolic homeostasis. Neuropharmacology 2011; epub ahead of print.
3. Janowska J, Zahorska-Markiewicz B, Olszanecka-Glinianowicz M: Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance. Metabolism 2006; 55: 1495-1499.
4. Banerjee RR, Rangwala SM, Shapiro JS, et al: Regulation of fasted blood glucose by resistin. Science 2004; 303: 1195-1198.
5. Rangwala SM, Rich AS, Rhoades B, et al: Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 2004; 53: 1937-1941.
6. Yang WS, Lee WJ, Funahashi T, et al: Plasma adiponectin levels in overweight and obese Asians. Obes Res 2002; 10: 1104-1110.
7. Steppan CM, Bailey ST, Bhat S, et al: The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312.
8. Lee JH, Chan JL, Yiannakouris N, et al: Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and inter -ventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 2003; 88: 4848-4856.
9. Al-Daghri NM, Al-Attas OS, Sallam R: Adipocytokine profiles as influenced by insulin resistance in obese subjects. Diabetes Metab Syndr: Clin Res Rev 2009; 3: 79-83.
10. Qi Q, Wang J, Li H, et al: Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese. Eur J Endocrinol 2008; 159: 585-593.
11. Fargnoli JL, Sun Q, Olenczuk D, et al: Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function. Eur J Endocrinol 2010; 162: 281-288.
12. Flier JS: Diabetes: the missing link with obesity? Nature 2001; 409: 292-293.
13. Kadowaki T, Yamauchi T, Kubota N, et al: Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784-1792.
14. Kern PA, Di Gregorio GB, Lu T, et al: Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes 2003; 52: 1779-1785.
15. Tomas E, Tsao TS, Saha AK, et al: Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A 2002; 99: 16309-16313.
16. Lindsay RS, Funahashi T, Hanson RL, et al: Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002; 360: 57-58.
17. Hotta K, Funahashi T, Arita Y, et al: Plasma levels of a novel adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599.
18. Nakashima Y, Inukai K, Imai K, et al: Involvement of low adiponectin levels in impaired glucose tolerance. Metabolism 2008; 57: 1350-1354.
19. Wasim H, Al-Daghri NM, Chetty R, et al: Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians. Cardiovasc Diabetol 2006; 5: 10.
20. Otsuka F, Sugiyama S, Kojima S, et al: Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men. Circ J 2007; 71: 1703-1709.
21. Snehalatha C, Mukesh B, Simon M, et al: Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 2003; 26: 3226-3229.
22. Hammana I, Malet A, Costa M, et al: Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis. Diabetes Metab 2007; 33: 213-219.
23. World Health Organization (WHO): Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation. Geneva, 8-11 December 2008. Geneva: WHO, 2011; pp 1-39.
24. Pickering TG, Hall JE, Appel LJ, et al: Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005; 45: 142-161.
25. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
26. Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
27. Steppan CM, Brown EJ, Wright CM, et al: A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A 2001; 98: 502-506.
28. Patel L, Buckels AC, Kinghorn IJ, et al: Resistin is expressed in human macrophages and directly regulated by PPARγ activators. Biochem Biophys Res Commun 2003; 300: 472-476.
29. Aruna B, Islam A, Ghosh S, et al: Biophysical analyses of human resistin: oligomer formation suggests novel biological function. Biochemistry 2008; 47: 12457-12466.
30. Verma S, Li SH, Wang CH, et al: Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003; 108: 736-740.
31. Pickup JC: Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27: 813-823.
32. Duncan BB, Schmidt MI: The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes. Diabetes Technol Ther 2006; 8: 7-17.
33. Kitagawa Y, Bujo H, Takahashi K, et al: Impaired glucose tolerance is accompanied by decreased insulin sensitivity in tissues of mice implanted with cells that overexpress resistin. Diabetologia 2004; 47: 1847-1853.
34. Satoh H, Nguyen MT, Miles PD, et al: Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest 2004; 114: 224-231.
35. Utzschneider KM, Carr DB, Tong J, et al: Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 2005; 48: 2330-2333.
36. Azuma K, Katsukawa F, Oguchi S, et al: Correlation between serum resistin level and adiposity in obese individuals. Obes Res 2003; 11: 997-1001.
37. Gui Y, Silha JV, Murphy LJ: Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes Res 2004; 12: 1481-1491.
38. Morash BA, Ur E, Wiesner G, et al: Pituitary resistin gene expression: effects of age, gender and obesity. Neuroendocrinology 2004; 79: 149-156.
39. Kochan Z, Karbowska J: Dehydro epiandrosterone up-regulates resistin gene expression in white adipose tissue. Mol Cell Endocrinol 2004; 218: 57-64.
40. Okamoto Y, Kihara S, Ouchi N, et al: Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002; 106: 2767-2770.
41. Maeda N, Shimomura I, Kishida K, et al: Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8: 731-737.
42. Dzienis-Straczkowska S, Straczkowski M, Szelachowska M, et al: Soluble tumor necrosis factor-α receptors in young obese subjects with normal and impaired glucose tolerance. Diabetes Care 2003; 26: 875-880.
43. Straczkowski M, Kowalska I, Stepien A, et al: Increased plasma-soluble tumor necrosis factor-α receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes Care 2002; 25: 1824-1828.